Measuring Tumor Epichaperome Expression Using [124I] PU-H71 Positron Emission Tomography as a Biomarker of Response for PU-H71 Plus Nab-Paclitaxel in HER2-Negative Metastatic Breast Cancer For ...
The FDA and Corbus Pharmaceuticals Holdings, Inc., have agreed on second-line registrational study designs evaluating CRB-701 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results